Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/18/2010CN101804148A Medicinal composition with function of improving sleeping and preparation method thereof
08/18/2010CN101804133A Traditional Chinese medicine composite used for treating infantile hypoevolutism and hypophrenia and preparation method thereof
08/18/2010CN101804127A Compound traditional Chinese medicine extractive composite for preventing and curing Alzheimer disease
08/18/2010CN101804125A Longan health wine
08/18/2010CN101804108A Traditional Chinese medicine composition for treating neurogenic headache
08/18/2010CN101804099A Preparation and sedative effect of acanthopanax fruit compound tablet
08/18/2010CN101804096A Method for extracting purified total alkaloid of strychnos nux-vomica and application thereof in pharmacy
08/18/2010CN101804086A Preparation method of fermented red ginseng product
08/18/2010CN101804072A Calculus bovis factitius superfine powder and preparation method
08/18/2010CN101804063A Application of panaxoside Pd in preparing medicament for curing neuropathic pain
08/18/2010CN101804043A Application of 2-phenylphenol and derivatives thereof to medicine for treating epilepsia
08/18/2010CN101804038A Huperzine A preparation for treating schizophrenia and nervous function damage and preparation method thereof
08/18/2010CN101305997B Medicament for treating nerve dysfunction after refraining opium type material
08/18/2010CN101229210B Applications of herba epimedii total flavone and notoginseng total saponin compounds
08/18/2010CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776917 Non-standard amino acid conjugates of amphetamine and processes for making and using the same
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776901 4-(6-spiro-1'-Cyclopropane-1a,6-dihydro-1H-cyclopropa[a]inden-6a-yl)-1H-imidazole, used for the treatment where the memory deficiency is associated with Alzheimer's disease and memory deficiency induced by scopolamine; side effect reduction
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776890 1H-indazole compounds
08/17/2010US7776882 such as 3-(2-Amino-6-phenoxy-3,4-dihydro-quinolin-3-yl)-N-cyclohexyl-N-methyl-propionamide, used in the treatment of Alzheimer's disease and related disorders
08/17/2010US7776871 for treatment of focal distonia, tremors, and parkinson's disease
08/17/2010US7776868 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7776852 Process for producing highly pure midazolam and salts thereof
08/17/2010US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776579 detoxifying a pathogenic prion protein by bringing a surface which may be contaminated with a pathogenic prion protein into contact with an enzyme exhibiting an activity of digesting a protein highly resistant to denaturation and degradation
08/17/2010US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776320 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2545092C Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2473201C Orodispersible pharmaceutical composition comprising agomelatine
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2467065C Preparation for improving the action receptors to neurotransmitters and/or neuromodulators
08/17/2010CA2455296C 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
08/17/2010CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2427227C Lactam compound
08/17/2010CA2425497C (n)-((s)-2-hydroxy-3-methyl-butyryl-1-(l-alaninyl)-(s)-1-amino-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-2-one dihydrate and its use in the treatment of alzheimer's disease
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2403086C Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/12/2010WO2010091009A1 Isoxazole-3-carboxamide derivatives
08/12/2010WO2010090494A2 Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof
08/12/2010WO2010090347A1 Dihydroquinolinone derivatives
08/12/2010WO2010090305A1 Substituted acylguanidine derivative
08/12/2010WO2010090304A1 Acylguanidine derivative
08/12/2010WO2010090300A1 Diazepinedione derivatives
08/12/2010WO2010090222A1 Hb-egf-bound protein complex
08/12/2010WO2010090009A1 Indoline derivatives
08/12/2010WO2010089706A1 Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy
08/12/2010WO2010089616A1 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010089442A1 Method for treating neurodegenerative diseases
08/12/2010WO2010089379A1 Method and means for producing tissues and tissues obtained
08/12/2010WO2010089292A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/12/2010WO2010089127A1 Substituted spiro-amides as b1r modulators
08/12/2010WO2010089122A2 Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010WO2010088729A1 Compositions and uses therefor
08/12/2010WO2010054126A3 Small molecule modulators of epigenetic regulation and their therapeutic applications
08/12/2010WO2010026021A3 Combination of extracts of various plants for improving the symptoms of dementia disorders
08/12/2010WO2010011546A3 Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity
08/12/2010WO2009130600A8 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
08/12/2010WO2007019344A8 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
08/12/2010US20100204469 Conjugated psychotropic drugs and uses thereof
08/12/2010US20100204333 Novel Pharmaceutical Modified Release Dosage Form Cyclooxygenase Enzyme Inhibitor
08/12/2010US20100204332 Method for treating a disease or condition responsive to opening of c1c-2 channel
08/12/2010US20100204330 Diclofenac Formulations and Methods of Use
08/12/2010US20100204309 Oligonucleotide compositions for the treatment of alzheimer's disease
08/12/2010US20100204306 Method of Treating Neurodegenerative Disease
08/12/2010US20100204304 NOGO Receptor Binding Protein
08/12/2010US20100204291 Method for Facilitating Extinction Training Using D-Cycloserine
08/12/2010US20100204285 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
08/12/2010US20100204276 Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/12/2010US20100204275 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/12/2010US20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
08/12/2010US20100204272 Compounds which have activity at M1 receptor and their uses in medicine
08/12/2010US20100204259 Immediate release composition resistant to abuse by intake of alcohol
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204251 Molecular target of neurotoxicity
08/12/2010US20100204247 N-substituted oxindoline derivatives as calcium channel blockers
08/12/2010US20100204245 Amino-pyridines As Inhibitors Of Beta-secretase
08/12/2010US20100204244 Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration
08/12/2010US20100204242 Piperazine Derivative Having Affinity for the Histamine H3 Receptor
08/12/2010US20100204233 Imidazole derivatives
08/12/2010US20100204230 Piperazine derivatives for treatment of ad and related conditions
08/12/2010US20100204227 Isoindoline compounds and methods of their use
08/12/2010US20100204224 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors
08/12/2010US20100204220 Heterocyclic modulators of cannabinoid receptors
08/12/2010US20100204214 Histamine h3 inverse agonists and antagonists and methods of use thereof
1 ... 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 ... 1833